Global Botulinum Toxin & HA Dermal Filler Market Research Report forecast 2018-2022
Summary - A new market study, titled “Global Botulinum Toxin
& HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)” has
been featured on Wise Guy Reports.
Botulinum Toxin (Botox or
BTX) is a poisonous natural protein, created by the bacteria named Clostridium
Botulinum. Generally, botulinum toxin is used by the surgeons to obstruct the
release of the neurotransmitter acetylcholine from axon endings at the
neuromuscular junction. According to the exotoxins, botulinum toxin can be
classified into eight product types including botulinum toxin A, B, C1, D, E,
F, G and H.
Hyaluronic Acid (HA) is a naturally occurring non-sulfated
glycosaminoglycan polymer component of the extracellular matrix that consists
of repeat disaccharide units of glucuronic acid and N-acetyl-glucosamine. HA
dermal fillers are widely used to replace and restore human tissue and are
commonly used in medical aesthetic surgeries. However, unlike botulinum toxin
which is directly used to restrict a particular muscle movement, HA dermal
fillers are directly injected into the skin to fill wrinkles /dermal or folded
points on the body part.
The U.S. emerged as a major region for the botulinum toxin
and HA dermal fillers market, due to increased demand for minimally invasive or
non-invasive facial cosmetic procedures by the residents of the U.S. supported
by growth in their respective disposable income and increased tertiary health
care concerns with the development of ageing symptoms.
The global botulinum toxin and HA dermal filler market is
expected to grow with emerging middle class population, rising female populace
in the workforce, increasing pharmaceutical R&D spending, growing health
care expenditure and accelerating economic growth. Key trends of this market
includes increasing plastic surgeon population, rising demand for minimally
invasive procedures in the U.S. and growing preference for combination therapy.
However, there are some factors which can hinder growth of
the market including stringent regulations, patient health-associated risks,
dominance of botulinum toxin and HA Dermal Filler alternatives and limited
access to patent rights.
The report “Global Botulinum Toxin and HA Dermal Filler
Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics
provides an extensive research and detailed analysis of the present market
along with future outlook. The report discusses the major growth drivers, key
tends & developments and challenges of the market, covering the U.S.,
Europe, Japan, Korea, China along with the global market. The report profiles
the key players of the market including Allergan Plc, Ipsen S.A., Shanghai
Haohai Biological Technology Co. Ltd and Medytox Inc.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3160184-global-botulinum-toxin-ha-dermal-filler-market-industry-analysis-outlook-2018-2022
About
Us :
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact
Us:
NORAH
TRENT
Ph:
+162-825-80070
(US)
Ph: +44 203
500 2763 (UK)
Comments
Post a Comment